CLINICAL_TRIALS
trial_result
· 2014-06-24
Clinical Trial Update: A Study Comparing AZD2014 vs Everolimus in Patients With Metastatic Renal Cancer [Phase 2]
Summary
A Phase 2 trial comparing AZD2014 and Everolimus in metastatic clear cell renal cell carcinoma has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Queen Mary University of London | Conditions: Metastatic Clear Cell Renal Carcinoma | Phase 2 | Status: TERMINATED